Publications - 'H'
Publications 126 - 150 de 1026
| Titre | DOI |
|---|---|
|
Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer F.M. Boyle; I.E. Smith; J. O'Shaughnessy; B. Ejlertsen; A.U. Buzdar; P. Fumoleau; W. Gradishar; M. Martin; B. Moy; M. Piccart-Gebhart; K.I. Pritchard; D. Lindquist; M. Amonkar; Y. Huang; E. Rappold; L.S. Williams; J. Wang-Silvanto; T. Kaneko; D.M. Finkelstein; P.E. Goss; T.E.A.C.H. Investigators 2015 |
10.1016/j.ejca.2015.02.005 |
|
Health research practices in a digital context J. Journot 2021 |
10.4000/communiquer.8704 |
|
Health risk assessment and decision-making for patient monitoring and decision-support using Wireless Body Sensor Networks C. Habib; A. Makhoul; R. Darazi; R. Couturier 2019 |
10.1016/j.inffus.2018.06.008 |
|
Health state prognostic of fuel cell based on wavelet neural network and cuckoo search algorithm K. Chen; S. Laghrouche; A. Djerdir 2021 |
10.1016/j.isatra.2020.03.012 |
|
Health technology assessments by the Haute Autorite de Sante (HAS) A. Bernard 2016 |
10.1016/j.rmr.2016.11.001 |
|
HEALTH UTILITY IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (RR-DLBCL) PATIENTS - RESULTS OF A PHASE II TRIAL WITH ORAL SELINEXOR R.O. Casasnovas; P. Daniele; G. Tremblay; M. Maerevoet; J. Zijlstra; G. Follows; J.S.P. Vermaat; N. Kalakonda; A.H. Goy; S. Choquet; E. Van den Neste; B.T. Hill; C. Thieblemont; F. Cavallo; F. de la Cruz; J. Kuruvilla; N. Hamad; R. Bouabdallah; U. Jaeger; P. Caimi; R. Gurion; K. Warzocha; S. Bakhshi; J.M. Sancho; M. Schuster; M. Egyed; F. Offner; T. Vasilakopoulos; P. Samal; A. Nagy; M. Ku; M.A.Canales Albendea 2020 |
|
|
Health-aware frequency separation method for online energy management of fuel cell hybrid vehicle considering efficient urban utilization M. Iqbal; H.S. Ramadan; M. Becherif 2021 |
10.1016/j.ijhydene.2021.02.072 |
|
Health-Conscious Energy Management for Fuel Cell Hybrid Electric Vehicles Based on Prognostics-Enabled Decision-Making M. Yue; S. Jemei; N. Zerhouni 2019 |
10.1109/TVT.2019.2937130 |
|
Health-related quality of life (HRQoL) assessment for patients with advanced renal cell carcinoma (aRCC) treated with a tyrosine kinase inhibitor (TKI) using electronic patient reported outcomes in daily clinical practice: QUANARIE trial G. Mouillet; A. Falcoz; P. Barthelemy; L. Geoffrois; S. Ladoire; J.C. Eymard; J. Plaza; E. Viel; T. Maurina; F. Calcagno; U. Stein; J. Fritzsch; O. Djoumakh; S. Paget-Bailly; A. Thiery-Vuillemin 2020 |
10.1016/j.annonc.2020.08.1525 |
|
Health-related quality of life (HRQoL) at final analysis of the GALAHAD study of niraparib in patients with metastatic castration-resistant prostate cancer (mCRPC) and DNA repair defects (DRD) M.R. Smith; S.K. Sandhu; D.J. George; K.N. Chi; F. Saad; A. Thiery-Vuillemin; O. Stahl; D. Olmos; D. Danila; R. Gafanov; E. Castro; H. Moon; A.M. Joshua; G.E. Mason; B.M. Espina; Y. Liu; K.B. Bevans; A. Lopez-Gitlitz; P. Francis; K. Fizazi 2021 |
10.1016/j.annonc.2021.08.1095 |
|
Health-related quality of life (HRQoL) for olaparib versus enzalutamide or abiraterone in metastatic castration-resistant prostate cancer (mCRPC) with homologous recombination repair (HRR) gene alterations: PROfound. A. Thiery-Vuillemin; J.S. De Bono; F. Saad; G. Procopio; N.D. Shore; K. Fizazi; G. Roubaud; Gdos Anjos; G. Gravis; J.Young Joung; N. Matsubara; D. Castellano; A. Degboe; C. Gresty; J. Kang; A. Allen; J.E. Burgents; M.H.A. Hussain 2020 |
|
|
Health-related quality of life (HRQoL) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in combination with abiraterone. N.W. Clarke; A. Thiery-Vuillemin; P.J. Wiechno; B. Alekseev; N. Sala; R. Jones; I. Kocak; V.Emanuele Chiuri; J. Jassem; A. Flechon; C. Redfern; C.Dietrich Goessl; J. Burgents; C. Gresty; A. Degboe; F. Saad 2019 |
10.1200/JCO.2019.37.7_suppl.234 |
|
Health-related quality of life as an endpoint in oncology phase I trials: a systematic review F. Fiteni; I. Le Ray; A. Ousmen; N. Isambert; A. Anota; F. Bonnetain 2019 |
10.1186/s12885-019-5579-3 |
|
Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma (mRCC) treated with a tyrosine kinase inhibitor (TKI) using electronic patient-reported outcomes in daily clinical practice: QUANARIE trial G. Mouillet; A. Falcoz; P. Barthelemy; L. Geoffrois; J.C. Eymard; S. Ladoire; J. Plaza; E. Viel; T. Maurina; F. Calcagno; J. Fritzsch; J. Fritzsch; O. Djoumakh; D. Vernerey; A. Thiery-Vuillemin; S. Paget-Bailly 2020 |
|
|
Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma (mRCC) treated with a tyrosine kinase inhibitor (TKI) using electronic patient-reported outcomes in daily clinical practice: QUANARIE trial G. Mouillet; A. Falcoz; P. Barthelemy; L. Geoffrois; J.C. Eymard; S. Ladoire; J. Plaza; E. Viel; T. Maurina; F. Calcagno; J. Fritzsch; J. Fritzsch; O. Djoumakh; D. Vernerey; A. Thiery-Vuillemin; S. Paget-Bailly 2020 |
|
|
Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma treated with a tyrosine kinase inhibitor using electronic patient-reported outcomes in daily clinical practice (QUANARIE trial): study protocol G. Mouillet; J. Fritzsch; S. Paget-Bailly; A. Pozet; I. Es-Saad; A. Meurisse; D. Vernerey; K. Mouyabi; D. Berthod; F. Bonnetain; A. Anota; A. Thiery-Vuillemin 2019 |
10.1186/s12955-019-1085-1 |
|
Health-related Quality of Life Following Hybrid Minimally Invasive Versus Open Esophagectomy for Patients With Esophageal Cancer, Analysis of a Multicenter, Open-label, Randomized Phase III Controlled Trial The MIRO Trial C. Mariette; S. Markar; T.Sandrine Dabakuyo-Yonli; B. Meunier; D. Pezet; D. Collet; X.Benoit D'Journo; C. Brigand; T. Perniceni; N. Carrere; J.Yves Mabrut; S. Msika; F. Peschaud; M. Prudhomme; F. Bonnetain; G. Piessen; FRENCH; FREGAT 2020 |
10.1097/SLA.0000000000003559 |
|
Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial G. Eberst; A. Anota; A. Scherpereel; J. Mazieres; J. Margery; L. Greillier; C. Audigier-Valette; D. Moro-Sibilot; O. Molinier; H. Lena; F. Riviere; I. Monnet; V. Gounant; H. Janicot; R. Gervais; C. Locher; E. Charton; F. Morin; G. Zalcman; V. Westeel; F.Cooperativ Interg 2019 |
10.1158/1078-0432.CCR-18-2860 |
|
Health-related quality of life in children interstitial lung disease N. Nathan; C. Lauby; R.Abou Taam; K. Bessaci; J. Brouard; M.L. Dalphin; C. Delacourt; C. Delestrain; A. Deschildre; J.C. Dubus; M. Fayon; L. Giovannini-Chami; V. Houdouin; A. Houzel; C. Marguet; I. Pin; P. Reix; M.C. Renoux; C. Schweitzer; A. Tatopoulos; C. Thumerelle; F. Troussier; S. Wanin; L. Weiss; A. Clement; P.Y. Boelle; R. Epaud 2019 |
10.1183/13993003.congress-2019.PA5184 |
|
Health-related quality of life in elderly patients with advanced non-small cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy F. Fiteni; A. Anota; F. Bonnetain; J.P. Oster; E. Pichon; M. Wislez; J. Dauba; D. Debieuvre; P.J. Souquet; L. Bigay-Game; O. Molinier; E. Dansin; M. Poudenx; B. Milleron; F. Morin; G. Zalcman; E. Quoix; V. Westeel 2016 |
10.1183/13993003.01695-2015 |
|
Health-related quality of life in elderly patients with advanced non-small-cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy in the Phase 3 IFCT-0501 trial F. Fiteni; A. Anota; F. Bonnetain; B. Milleron; G. Zalcman; E. Quoix; V. Westeel 2015 |
10.1016/S0959-8049(16)31696-3 |
|
Health-related quality of life in infants and children with interstitial lung disease C. Lauby; P.Y. Boelle; R.Abou Taam; K. Bessaci; J. Brouard; M.L. Dalphin; C. Delacourt; C. Delestrain; A. Deschildre; J.C. Dubus; M. Fayon; L. Giovannini-Chami; V. Houdouin; A. Houzel; C. Marguet; I. Pin; P. Reix; M.C. Renoux; C. Schweitzer; A. Tatopoulos; C. Thumerelle; F. Troussier; S. Wanin; L. Weiss; A. Clement; R. Epaud; N. Nathan 2019 |
10.1002/ppul.24308 |
|
Health-related quality of life in patients treated for ovarian cancer: Tools and issues A. Bryand; Z. Hamidou; S. Paget-Bailly; F. Bonnetain; C. Mathelin; J.J. Baldauf; C. Akladios 2015 |
10.1016/j.gyobfe.2014.12.011 |
|
Health-related quality of life in phase III cancer clinical trials: From questionnaire administration to statistical analysis F. Fiteni; A. Anota; V. Westeel; F. Bonnetain 2015 |
10.1016/j.bulcan.2015.02.014 |
|
Health-related quality of life in the early-access phase IIIb study of trifluridine/tipiracil in pretreated metastatic colorectal cancer (mCRC): Results from PRECONNECT study. J. Taieb; T.Jay Price; F. Ciardiello; M. Peeters; L. Wyrwicz; J.B. Bachet; C. Borg; C. de la Fouchardiere; M. Becquart; N. Mounedji; L. Vidot; J. Sabater; A. Falcone 2019 |
10.1200/JCO.2019.37.4_suppl.638 |